ADIAL PHARMACEUTICALS CEO William Stilley's 2021 pay rises 8% to $1.2M

ADIAL PHARMACEUTICALS reports 2021 executive compensation

By ExecPay News

Published: September 1, 2022

ADIAL PHARMACEUTICALS reported fiscal year 2021 executive compensation information on September 1, 2022.
In 2021, three executives at ADIAL PHARMACEUTICALS received on average a compensation package of $773K, a 2% decrease compared to previous year.
Average pay of disclosed executives at ADIAL PHARMACEUTICALS
William B. Stilley, Chief Executive Officer, received $1.2M in total, which increased by 8% compared to 2020. 52% of Stilley's compensation, or $633K, was in option awards. Stilley also received $115K in bonus, $409K in salary, as well as $71K in other compensation.
Joseph A. M. Truluck, Chief Financial Officer, received a compensation package of $625K, which increased by 38% compared to previous year. 51% of the compensation package, or $316K, was in option awards.
Cary J. Claiborne, Chief Executive Officer, earned $467K in 2021.

Related executives

William Stilley

ADIAL PHARMACEUTICALS

Chief Executive Officer

Cary Claiborne

ADIAL PHARMACEUTICALS

Chief Executive Officer

Joseph Truluck

ADIAL PHARMACEUTICALS

Chief Financial Officer

You may also like

Source: SEC filing on September 1, 2022.